L-Leucyl-D-Valine for Liquid Phase Peptide Synthesis | NINGBO INNO
Stereochemical Equivalency Validation Against INDOFINE 04-1998 L-Leucyl-D-valine Standards
In the context of advanced peptide synthesis, maintaining chiral integrity is paramount, particularly when utilizing dipeptide fragments like L-Leucyl-D-Valine (CAS: 17665-00-8). Our manufacturing process prioritizes stereochemical stability to ensure equivalency against recognized reference standards, such as INDOFINE 04-1998. During the synthesis route, specific attention is paid to the activation of the carboxylic terminus to prevent racemization, a common failure mode in dipeptide coupling.
Field observations indicate that prolonged exposure to basic conditions during the final neutralization step can induce slight epimerization at the C-terminal valine residue. To mitigate this, our process engineers control the pH trajectory strictly during workup. This ensures that the L-Leu-D-Val configuration remains intact, providing a reliable building block for downstream elongation. When validating this material against legacy standards, R&D teams should focus on chiral HPLC separation factors rather than relying solely on optical rotation, as solvent interactions can skew polarimetric data.
HPLC Purity Profiles and Chiral Impurity Limits for Liquid-Phase Synthesis
Liquid-Phase Peptide Synthesis (LPPS) demands higher purity profiles compared to solid-phase methods due to the accumulation of impurities in homogeneous solutions. For Leucylvaline derivatives, the primary concern is the presence of diastereomers, specifically the L-Leu-L-Val isomer, which is difficult to separate once coupled into longer chains. Our analytical protocols utilize chiral stationary phases to quantify these impurities at trace levels.
Typical chromatographic profiles show a dominant peak for the target dipeptide, with impurity peaks resolved based on hydrophobicity differences. In industrial purity grades, the focus is on minimizing deletion sequences and uncoupled starting materials. We recommend running system suitability tests with each batch to confirm resolution between the D-Val and L-Val containing species. This level of scrutiny ensures that the H-Leu-Val-OH fragment does not introduce stereochemical errors into the final therapeutic peptide sequence.
Critical COA Parameters for Chiral Integrity and Assay Potency in Fmoc Chemistry
When integrating this dipeptide into Fmoc-based strategies, the Certificate of Analysis (COA) must reflect parameters beyond standard assay potency. Critical quality attributes include water content, residue on ignition, and specific chiral purity limits. Below is a comparison of typical technical parameters expected for high-grade pharmaceutical intermediates.
| Parameter | Typical Specification | Test Method |
|---|---|---|
| Assay (HPLC) | >98.0% | Area Normalization |
| Chiral Purity | >99.0% (de) | Chiral HPLC |
| Loss on Drying | <0.5% | Karl Fischer / LOD |
| Residue on Ignition | <0.1% | Gravimetric |
| Optical Rotation | Specific to Batch | Polarimetry |
Please note that while these values represent our standard manufacturing controls, exact numerical specifications vary by production lot. Please refer to the batch-specific COA for confirmed data upon receipt. NINGBO INNO PHARMCHEM CO.,LTD. maintains rigorous documentation to support regulatory filings without making unauthorized environmental claims.
Compatibility with DIC Coupling and TFA Deprotection in Dichloromethane Systems
Compatibility with standard coupling reagents such as Diisopropylcarbodiimide (DIC) is essential for seamless integration into existing workflows. In dichloromethane (DCM) systems, Leu-Val Dipeptide solubility can present handling challenges during concentration steps. A non-standard parameter often overlooked in basic datasheets is the solubility precipitation threshold during rotary evaporation.
Field experience suggests that as DCM is removed under vacuum, the dipeptide may begin to crystallize prematurely if the temperature drops below 25°C, potentially trapping solvent inclusions. To avoid this, we recommend maintaining the bath temperature at 30-35°C during solvent exchange or switching to a co-solvent system involving DMF if solubility issues persist. Furthermore, during TFA deprotection, the stability of the peptide bond must be monitored. While generally stable, prolonged exposure to neat TFA at elevated temperatures can lead to minor degradation. Optimizing deprotection time ensures maximum recovery of the active amino acid derivative without compromising the backbone integrity.
Bulk Packaging Configurations and Stability Data for Organic Solvent Storage
For scale-up operations, physical packaging directly impacts material stability during transit and storage. We supply bulk quantities in sealed 25kg fiber drums with polyethylene liners or 210L drums for larger volumes. The focus is on moisture exclusion and physical protection rather than regulatory certifications. Stability data indicates that the material remains within specification for 24 months when stored in a cool, dry place away from direct sunlight.
Organic solvent residues, if present from the crystallization process, are managed through controlled drying cycles. We do not claim specific environmental certifications; instead, we focus on factual shipping methods and robust physical containment to ensure the product arrives in the condition specified on the COA. Proper inventory rotation (FIFO) is advised to maintain optimal potency for sensitive manufacturing process applications.
Frequently Asked Questions
What is the typical lead time for bulk orders of L-Leucyl-D-Valine?
Standard lead times vary based on current inventory levels and production scheduling. For established grades, shipment can often be arranged within 2-4 weeks. Please contact our sales team for a specific timeline based on your required quantity.
Can you provide a sample for method validation before purchase?
Yes, we support R&D validation efforts. Sample quantities are available upon request to allow your team to verify compatibility with your specific synthesis route and analytical methods.
Is the material supplied with a Certificate of Analysis?
Every shipment includes a batch-specific Certificate of Analysis detailing assay, chiral purity, and physical constants. Please refer to the batch-specific COA for exact numerical values.
What payment terms are available for international procurement?
We offer standard international payment terms suitable for B2B transactions. Specific terms are negotiated based on the volume of the order and the established credit relationship.
Sourcing and Technical Support
Securing a stable supply of critical peptide building blocks requires a partner with deep technical understanding and manufacturing capacity. Our team is equipped to handle custom specifications and provide the documentation necessary for your quality assurance protocols. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.